OBJECTIVE: To identify clinical characteristics associated with high maximum oxytocin doses in women who achieve complete cervical dilation. METHODS: A retrospective nested case-control study was performed within a cohort of all term women at a single center between 2004 and 2008 who reached the second stage of labor. Cases were defined as women who had a maximum oxytocin dose during labor >20 mu/min, while women in the control group had a maximum oxytocin dose during labor of ≤20 mu/min. Exclusion criteria included no oxytocin administration during labor, multiple gestations, major fetal anomalies, nonvertex presentation, and prior cesarean delivery. Multiple maternal, fetal, and labor factors were evaluated with univariable analysis and multivariable logistic regression. RESULTS: Maximum oxytocin doses >20 mu/min were administered to 108 women (3.6%), while 2864 women received doses ≤20 mu/min. Factors associated with higher maximum oxytocin dose after adjusting for relevant confounders included maternal diabetes, birthweight >4000 g, intrapartum fever, administration of magnesium, and induction of labor. CONCLUSIONS: Few women who achieve complete cervical dilation require high doses of oxytocin. We identified maternal, fetal and labor factors that characterize this group of parturients.
OBJECTIVE: To identify clinical characteristics associated with high maximum oxytocin doses in women who achieve complete cervical dilation. METHODS: A retrospective nested case-control study was performed within a cohort of all term women at a single center between 2004 and 2008 who reached the second stage of labor. Cases were defined as women who had a maximum oxytocin dose during labor >20 mu/min, while women in the control group had a maximum oxytocin dose during labor of ≤20 mu/min. Exclusion criteria included no oxytocin administration during labor, multiple gestations, major fetal anomalies, nonvertex presentation, and prior cesarean delivery. Multiple maternal, fetal, and labor factors were evaluated with univariable analysis and multivariable logistic regression. RESULTS: Maximum oxytocin doses >20 mu/min were administered to 108 women (3.6%), while 2864 women received doses ≤20 mu/min. Factors associated with higher maximum oxytocin dose after adjusting for relevant confounders included maternal diabetes, birthweight >4000 g, intrapartum fever, administration of magnesium, and induction of labor. CONCLUSIONS: Few women who achieve complete cervical dilation require high doses of oxytocin. We identified maternal, fetal and labor factors that characterize this group of parturients.
Authors: Joyce A Martin; Brady E Hamilton; Stephanie J Ventura; Michelle J K Osterman; Sharon Kirmeyer; T J Mathews; Elizabeth C Wilson Journal: Natl Vital Stat Rep Date: 2011-11-03
Authors: Erin L Reinl; Zane A Goodwin; Nandini Raghuraman; Grace Y Lee; Erin Y Jo; Beakal M Gezahegn; Meghan K Pillai; Alison G Cahill; Cristina de Guzman Strong; Sarah K England Journal: Am J Obstet Gynecol Date: 2017-04-26 Impact factor: 8.661
Authors: Manasi Malik; Michael D Ward; Yingye Fang; Justin R Porter; Maxwell I Zimmerman; Thomas Koelblen; Michelle Roh; Antonina I Frolova; Thomas P Burris; Gregory R Bowman; Princess I Imoukhuede; Sarah K England Journal: ACS Pharmacol Transl Sci Date: 2021-09-08
Authors: Lin Zhang; James Troendle; D Ware Branch; Matthew Hoffman; Jun Yu; Lixia Zhou; Tao Duan; Jun Zhang Journal: PLoS One Date: 2018-10-31 Impact factor: 3.240